Therapeutic agent for restenosis
US7910611B2 · kind B2 · utility
0Cited by
19References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 22, 2006 |
| Grant date | Mar 22, 2011 |
| Priority date | — |
| Expiry date | Sep 30, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic and/or prophylactic agent for restenosis, which comprises a thiadiazoline derivative represented by the general formula (0), or a pharmaceutically acceptable salt thereof:[wherein, n represents an integer of 1 to 3, R0 represents aryl, —NR1CONR2 (wherein R1 represents a hydrogen atom or the like, and R2 represents lower alkyl or the like) or the like, R3 represents lower alkyl, R4 represents a hydrogen atom or the like, and R5 represents aryl or the like].
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.